Market News
Latest news from Stock markets.
BP profits soar as oil volatility boosts trading arm
BP PLC (LSE:BP.) returned to profit in the first quarter, helped by stronger trading and refining as oil prices surged and then fluctuated wildly in the aftermath of the Iran war.
...keep reeding on proactiveinvestors.co.uk
Genflow widens confidentiality agreements with animal health companies over dog gene therapy data
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the gene therapy developer, has signed additional confidentiality agreements with Tier-1 global animal health companies as interest grows in its canine ageing programme. The agreements follow positive preliminary interim results from the company's dog study, announced in February, and build on an initial round of confidentiality agreements already in place.
...keep reeding on proactiveinvestors.co.uk
Alphabet Earnings Preview: Q1 2026
According to Visible Alpha consensus, Alphabet Inc.'s total revenues expected for Q1 2026 have increased to $106.9 billion from $101.5 billion in the fall. The Q1 consensus expectations for operating income and EPS have also increased due to a higher Cloud margin expectation. Looking ahead to Q2 2026, analysts now expect the Cloud business to generate a 29.8% operating profit margin, up 900 bps year over year.
...keep reeding on seekingalpha.com
Norwood Financial: Reaction To Q1 Results Provides Investment Opportunity (Rating Upgrade)
Norwood Financial earns a Buy rating as Q1 2026 results and valuation signal improved outlook and risk-reward for small-cap bank investors. Despite merger-related noise, NWFL demonstrated 14.3% adjusted EPS growth and 34.9% revenue growth year-over-year, with tangible book value impact less severe than expected. Loan yields rose to 6.28%, net interest margin improved to 3.68%, and asset quality remains reasonable despite CRE exposure and rural market risks.
...keep reeding on seekingalpha.com
Securitas AB Interim Report Q1 2026 | January-March
STOCKHOLM, April 28, 2026 /PRNewswire/ -- January–March 2026 Total sales MSEK 36 211 (39 606) Organic sales growth 0 percent (3) Adjusted organic sales growth, 2 percent* Real sales growth within technology and solutions 4 percent (5) Operating income before amortization MSEK 2 459 (2 525) Operating margin 6.8 percent (6.4) Adjusted operating margin, 7.0 percent (6.7)* Items affecting comparability (IAC) MSEK 184 (–77) whereof MSEK 213 (–5) related to divestitures Earnings per share, SEK 2.80 (2.29) Earnings per share before IAC, SEK 2.47 (2.36) Cash flow from operating activities 40 percent (1) Net debt/EBITDA ratio 2.2 (2.5) * A new key ratio, operating margin adjusted for the government business within SCIS in the process of being closed down, was added as of the second quarter 2025. A new key ratio, organic sales growth adjusted for the same business, was added as of the third quarter 2025.
...keep reeding on prnewswire.com
Santhera reconfirms cash flow breakeven target as AGAMREE revenues near-double
The Swiss rare disease specialist expects to reach breakeven in the third quarter of 2026 without raising additional funds. Santhera Pharmaceuticals (SIX:SANN, OTC:SPHDF, FRA:S3F0), the Swiss specialty pharma group listed on the SIX Swiss Exchange, has reconfirmed it expects to reach cash flow breakeven during the third quarter of 2026, requiring no additional fundraising, as its Duchenne muscular dystrophy (DMD) drug AGAMREE delivered revenues well ahead of guidance.
...keep reeding on proactiveinvestors.co.uk
Raiffeisenbankengruppe Oesterreich (excluding Raiffeisen Bank International) Selects nCino to Modernise Corporate Lending Across Its Nationwide Network
One of Europe's largest cooperative banking institutions to standardise lending operations on the nCino Platform One of Europe's largest cooperative banking institutions to standardise lending operations on the nCino Platform
...keep reeding on globenewswire.com
Quadient and Solix Strengthen SaaS Communications Lifecycle with Expansion of Advanced Enterprise Archiving
Paris Quadient (Euronext Paris: QDT), a global automation platform powering secure and sustainable business connections, announced today that together with its partner Solix Technologies, it is expanding the availability of Quadient Inspire Digital Vault, a secure cloud-native archiving and retrieval solution for storing, managing and retrieving high-volume customer communications and enterprise records. First successfully launched in Europe and APAC in September 2024, Inspire Digital Vault is now available in North America and South America.
...keep reeding on globenewswire.com
Poolbeg Pharma eyes partnering deals as cancer immunotherapy trial heads for summer data
Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, is advancing partnering discussions with multiple pharmaceutical companies as it moves towards a series of near-term clinical data readouts that management believes could catalyse a deal. Its lead programme, POLB 001, is being developed as a preventative therapy for Cytokine Release Syndrome (CRS), a potentially life-threatening immune overreaction triggered by certain cancer immunotherapies, particularly bispecific antibodies, which work by simultaneously binding to cancer cells and immune cells to direct an attack on tumours.
...keep reeding on proactiveinvestors.co.uk
WPP Posts Decline in Key Metric Amid Broad Growth Slowdown
The advertising group reported a decline across all its main units, as it seeks to turn around its fortunes after a series of account losses and a leadership change.
...keep reeding on wsj.com
BP Gets Earnings Bump as Oil Traders Capitalize on War-Induced Volatility
Quarterly earnings more than doubled as BP's traders capitalized on market volatility triggered by the conflict in the Middle East.
...keep reeding on wsj.com
Banco Comercial Português, S.A. informs about Bank Millennium (Poland) preliminary unaudited results in Q1 2026
Banco Comercial Português, S.A. informs about Bank Millennium (Poland) preliminary unaudited results in Q1 2026 Attachment 2026 04 28 Resultados Polónia_EN
...keep reeding on globenewswire.com
Insight Enterprises: Looking For Greater Insights
Insight Enterprises trades at just 7x adjusted earnings, with manageable leverage and record profitability despite recent revenue declines. Insight's shift toward higher-margin services supports operating margin expansion, offsetting topline softness and positioning for a return to sales growth in 2026. Recent acquisitions, including Inspire11, enhance Insight's AI and systems integration capabilities, potentially closing the AI gap and driving future growth.
...keep reeding on seekingalpha.com
Scancell wins FDA fast-track status for melanoma immunotherapy
The AIM-listed biotech reports 77% progression-free survival at 20 months, well ahead of the standard of care Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the cancer immunotherapy developer, has secured a Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its lead drug candidate, iSCIB1+, in advanced melanoma.
...keep reeding on proactiveinvestors.co.uk
Barclays reports flat first-quarter profit as provision mars strong trading
Barclays reported first-quarter profit in line with expectations on Tuesday, as a 200 million pound ($270 million) provision for a loss to a single company exposure was counterbalanced by a steady performance from its investment bank thanks to robust trading.
...keep reeding on reuters.com
Oil giant BP announces huge rise in profits in first results since Iran war
The oil and gas producing giant BP has recorded a more than doubling of profits as it benefits from high prices from the Iran war.
...keep reeding on news.sky.com
BP profit beats expectations at $3.2 billion
BP on Tuesday posted a first-quarter underlying replacement cost profit, its version of net income, of $3.2 billion, compared with expectations of $2.67 billion in a company-provided poll of analysts and $1.38 billion a year ago.
...keep reeding on reuters.com
Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for bepirovirsen, an investigational antisense oligonucleotide (ASO) for the treatment of adults with chronic hepatitis B (CHB). The FDA has granted bepirovirsen Breakthrough Therapy designation and set a Prescription Drug User Fee Act (PDUFA) target action date of October 26, 2026. “.
...keep reeding on businesswire.com
Oil major BP beats profit expectations as Iran war boosts fuel prices
The results come shortly after BP's board suffered a shareholder revolt at its annual general meeting.
...keep reeding on cnbc.com
Boehringer-Zealand drug leads to 16.6% weight loss in late-stage trial
Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in a late-stage trial, as the unlisted German drugmaker seeks to catch up with obesity drug pioneers Eli Lilly and Novo Nordisk.
...keep reeding on reuters.com
Southern Energy Corp. Announces Fourth Quarter And Year End 2025 Financial And Operating Results
CALGARY, AB / ACCESS Newswire / April 28, 2026 / Southern Energy Corp. ("Southern" or the "Company") (TSXV:SOU)(AIM:SOUC), an established producer with natural gas and light oil assets in Mississippi, announces its fourth quarter and year end December 31, 2025 financial and operating results. Selected financial and operational information is outlined below and should be read in conjunction with the Company's audited consolidated financial statements and related management's discussion and analysis (the "MD&A") for the three and twelve months ended December 31, 2025, as well as the Company's annual information form for the year ended December 31, 2025, (the "AIF"), all of which are available on the Company's website at www.southernenergycorp.com and have been filed under the Company's profile on SEDAR+ at www.sedarplus.ca.
...keep reeding on accessnewswire.com
Apex Drills 4.02% REO over 23.7 m, within Broader 124 m Zone at 1.94% REO, Extending Mineralization Significantly to the South
Highlights: RIFT26-003 was a 120 m southern step-out from the previously reported RIFT26-002 (81.6 m of 2.02% REO, including 50.9 m of 2.40% REO), demonstrating significant grade and scale potential along strike within interpreted 700 m mineralized corridor. 80.0 m at 2.29% REO(1) , including 23.7 m at 4.02% REO within a broader mineralized interval of 124 m at 1.94% REO (see Figure 1).
...keep reeding on accessnewswire.com
Mkango Resources Limited Announces Opening of Hypromag Plant in Pforzheim
GERMAN FEDERAL MINISTRY FOR ECONOMIC AFFAIRS AND ENERGY OFFICIALLY OPENS HYPROMAG PLANT IN PFORZHEIM LONDON, UK AND VANCOUVER, BC / ACCESS Newswire / April 28, 2026 / Mkango Resources Ltd. (AIM:MKA)(TSXV:MKA) ("Mkango") is pleased to announce that its subsidiary, HyProMag GmbH ("HyProMag") will today officially open its rare earth magnet recycling and manufacturing plant (the "Plant") in Pforzheim, Germany.
...keep reeding on accessnewswire.com
Caledonia Mining Corporation Plc: Notice of Q1 2026 Results and Investor Presentation
SAINT HELIER, JE / ACCESS Newswire / April 28, 2026 / Caledonia Mining Corporation Plc (NYSE:CMCL)(AIM:CMCL)(AMEX:CMCL) ("Caledonia" or "the Company") expects to publish its operating and financial results for the quarter ended March 31, 2026 on Monday May 11, 2026. A remote presentation for analysts and investors will be held on the same day, at 2:00pm London time, followed by an opportunity to ask questions.
...keep reeding on accessnewswire.com
STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors
STMicroelectronics brings always-on vision to next-generation personal electronics with new ultralow-power image sensors VD55G4 and VD65G4 extend the ST BrightSense portfolio with compact, ultralow-power, microcontroller-compatible sensors for wearables, AR/VR, and smart devices These new global-shutter image sensors can consume up to 10x less, in operating mode at around 800×700 resolution and 10 frames per second Geneva, Switzerland — April 28, 2026 — STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, introduces a new generation of ultralow-power global-shutter image sensors that deliver high-quality, always-on vision to compact devices operating on batteries or harvested energy. The VD55G4 (monochrome) and VD65G4 (RGB color) sensors, part of the ST BrightSense portfolio, are now available to early adopters, enabling customers to start designing their next generation of smart, ultralow-power vision devices today.
...keep reeding on globenewswire.com
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 28
LONDON, UK / ACCESS Newswire / April 28, 2026 / The Company announces that on 27 April 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
...keep reeding on accessnewswire.com
Hemogenyx Pharmaceuticals PLC Announces Institutional Fundraise
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
...keep reeding on accessnewswire.com
Coca-Cola Europacific Partners plc Announces Q1 Trading Update & Interim Dividend Declaration
UXBRIDGE, ENGLAND / ACCESS Newswire / April 28, 2026 / COCA-COLA EUROPACIFIC PARTNERS Trading Update for the First Quarter ended 03 April 2026 & Interim Dividend Declaration Good start to the year; reaffirming full-year guidance Q1 2026 Change vs 2025 Revenue Volume (UC)[2] Revenue per UC[1],[2],[3] Volume* Revenue per UC[1],[2],[3] FXN[1],[3] Revenue Revenue Europe €3,549m 596m €6.00 8.4% 1.3% 9.8% 9.1% APS €1,452m 374m €4.17 8.7% (0.3)% 8.6% 1.1% CCEP €5,001m 970m €5.29 8.5% 0.8% 9.4% 6.7% Damian Gammell, Chief Executive Officer, said: "We've had a good start to the year with more balanced topline delivery. Although stronger volumes benefitted from calendar phasing and an earlier Easter, we delivered solid comparable volume growth and share gains driven by great execution.
...keep reeding on accessnewswire.com
Plaid Technologies Announces Definitive Graphene Supply Agreement, Marketing Agreement and Private Placement
Vancouver, British Columbia – TheNewswire - April 28, 2026 — Plaid Technologies Inc. (CSE: STIF) (OTC: STIFF) (FRA: 5QX0) (“ Plaid ” or the “ Company”) is pleased to announce that it has entered into a definitive supply agreement (the “ Definitive Agreement ”) with a European-based producer and supplier of high-quality graphene. The Definitive Agreement has a term of 24 months and provides Plaid with expanded access to graphene under the following tiered pricing structure (all amounts in Canadian dollars):
...keep reeding on thenewswire.com
Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase 3 trial
Company announcement – No. 10 / 2026 Zealand Pharma announces Boehringer Ingelheim's novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people living with obesity or overweight in Phase 3 trial In SYNCHRONIZE-1, participants lost up to an average of 39.2 lb (17.8 kg) from baseline after 76 weeks of treatment with survodutide, a glucagon/GLP-1 receptor dual agonist1 The trial met both weight loss primary endpoints and its key secondary endpoint evaluating waist circumference, a predictor of cardiometabolic risk, together demonstrating survodutide's potential to broadly improve metabolic health1 In addition to these positive results, Boehringer is advancing its broad metabolic health R&D program, exploring multiple pharmaceutical approaches to weight management including oral treatments.
...keep reeding on globenewswire.com
Orosur Mining Inc Announces El Cedro Sampling Opens New Horizons
Soil sampling completed at El Cedro south - prospectivity enhanced Aeromag over El Cedro and APTA now completed Pepas rig moved from Pepas West to new target LONDON, UK / ACCESS Newswire / April 28, 2026 / Orosur Mining Inc. ("Orosur" or the "Company") (TSXV:OMI)(AIM:OMI), is pleased to announce an update on the progress of exploration activities at the Company's exploration project at Anzá in Colombia ("Anzá"). Anzá - Colombia The Anzá Project in Colombia comprises a number of granted exploration titles and applications totalling roughly 330km2, within the Mid-Cauca gold belt, west of the city of Medellin.
...keep reeding on accessnewswire.com
Genflow Biosciences PLC Announces Expansion of Confidentiality Agreements
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED.
...keep reeding on accessnewswire.com
Ondo Finance Brings Shareholder Voting Capabilities to Tokenized Securities with Broadridge
Ondo is partnering with Broadridge to enable holders of tokenized stocks and ETFs to participate in proxy voting and access regulatory filings and issuer communications for underlying securities NEW YORK, April 28, 2026 /PRNewswire/ -- Ondo Finance, a blockchain-based platform focused on tokenizing real-world assets, today announced a partnership with global fintech leader Broadridge Financial Solutions (NYSE: BR) that, for the first time, enables holders of third party tokenized stocks and ETFs to participate in proxy voting. "By working with Broadridge, we are enabling holders of our on-chain tokenized stocks to access governance and voting capabilities, with all the additional benefits on-chain tokens provide," said Matthieu de Vergnes, MD, Global Head of Institutional at Ondo Finance.
...keep reeding on prnewswire.com
Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study
Potent and durable efficacy with iSCIB1+ of 77% progression free survival (PFS) at 20 months, in combination with ipilimumab and nivolumab, demonstrated in the Phase 2 SCOPE trial; more PFS and additional early overall survival (OS) data expected in H1 2027
...keep reeding on globenewswire.com
Air Liquide Revenue Rises on Gas, Services Business Strength
First-quarter revenue at the industrial-gases company rose 1.9% on a comparable basis to €6.79 billion.
...keep reeding on wsj.com
LendingClub Corporation (LC) Q1 2026 Earnings Call Transcript
LendingClub Corporation (LC) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
UMH Preferred: A 7.3% Yield And A Discount To Par
UMH Properties' 6.375% Series D preferred shares trade at a ~12.5% discount to par, yielding ~7.3%, offering both income and capital appreciation potential. Strong FFO coverage (~4–5x) and consistent dividend history suggest the relative safety of UMH.PR.D's payouts, supported by the REIT's current liquidity and moderate debt maturities. Manufactured housing's affordability drives demand resilience, offsetting interest rate headwinds and supporting UMH's stable cash flows for preferred and common dividends.
...keep reeding on seekingalpha.com
Publication of the Q1 2026 financial results on Tuesday, May 5, 2026, after market close
Paris, France – April 28, 2026 Q1 2026 financial results and conference call Viridien will publish its first quarter 2026 results on Tuesday, May 5, after market close. The press release and presentation will be made available on www.viridiengroup.com at 5.45 pm (CET) An English-language conference call is scheduled at 6.00 pm (CET) on the same day Participants must register for the conference call by clicking here to receive a dial-in number and PIN code.
...keep reeding on globenewswire.com
Why This Week Could Be Huge For AI Stocks
AI stocks jumped in the wake of strong earnings reports this week. Most of the "Magnificent Seven" will report earnings this week.
...keep reeding on fool.com
LendingClub: Strong Originations Amid Private Credit Meltdown Ahead Of Rebrand
LendingClub remains a compelling "Buy," bolstered by strong Q1 results and resilient credit metrics despite broader market fears. LC is delivering over 30% originations growth, supporting robust non-interest fee income and reinforcing its growth profile. Deposit growth, high-yield savings, and the rebrand to Happen Bank are reducing the cost of capital and enhancing net interest margins.
...keep reeding on seekingalpha.com
Air Liquide posts slight Q1 revenue miss
French industrial gases group Air Liquide on Tuesday reported slightly lower than expected revenue for the first quarter.
...keep reeding on reuters.com
Alm. Brand A/S - Interim report for Q1 2026
Very satisfactory insurance service result supported by underlying improvements in Commercial Lines Alm. Brand Group lifts its guidance for the insurance service result excluding run-off gains or losses for the second to fourth quarter of 2026 by DKK 150 million to DKK 1.8-2.0 billion.
...keep reeding on globenewswire.com
European markets to open higher as Trump considers Iran peace proposal
European stocks are expected to open higher on Tuesday as investors assess the latest developments in the Iran war, and look ahead to earnings reports.
...keep reeding on cnbc.com
Indian court pauses stricter power grid penalties for renewable firms
A court in the southern Indian state of Karnataka has temporarily blocked new, tougher penalties for solar and wind power producers for deviating from scheduled grid supply after industry bodies challenged the rules.
...keep reeding on reuters.com
Novartis Q1 profit down on US generic erosion
Swiss drugmaker Novartis reported first-quarter core operating profit below market expectations on Tuesday, as generic competition for its top-selling heart drug Entresto weighed on sales.
...keep reeding on reuters.com
Coronado Global Resources Inc. (CODQL) Q1 2026 Earnings Call Transcript
Coronado Global Resources Inc. (CODQL) Q1 2026 Earnings Call Transcript
...keep reeding on seekingalpha.com
Pathward Financial: Credit Deterioration Is Concerning (Downgrade)
Pathward Financial is downgraded to "Sell" due to deteriorating credit quality and insufficient loan loss reserves. Despite stable capital ratios and aggressive buybacks, NPLs have nearly tripled to 2.39%, with reserves now covering less than 1x NPLs. Loan growth remains robust, but underwriting standards appear lax, increasing exposure to riskier credits as government guarantees decline.
...keep reeding on seekingalpha.com
Google signs classified AI deal with Pentagon, The Information reports
Alphabet's Google has signed a deal with the U.S. Department of Defense to use its AI models for classified work, the Information reported on Tuesday, citing a person familiar with the matter.
...keep reeding on reuters.com
Exclusive: China's Hongqi, once favoured by Mao, eyes Stellantis Spain plant for European expansion
Chinese luxury automaker Hongqi, famed as Mao Zedong's preferred car brand, is in talks with Stellantis to build vehicles at one of the Fiat-to-Jeep owner's Spanish plants as it expands in Europe, five sources familiar with the matter said.
...keep reeding on reuters.com
Meta, Google, OpenAI among Big Tech firms seeing top staff leaving to launch AI startups
Big Tech firms are increasingly seeing top researchers depart to launch their own AI ventures. Many are raising huge sums with months of setting up startups, as investors bet big on novel approaches to model architecture.
...keep reeding on cnbc.com
Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 28, 2026, at 14:00 CEST / 13:00 BST / 08:00 EDT.
...keep reeding on globenewswire.com